leadf
logo-loader
OTCQB:TOMDF

Todos Medical Ltd.

Receive alerts
Market:
OTCQB
Market Cap:
$8.46 m
Price
0.04 USD
Change
-3.68%
52 weeks high
0.18
52 weeks low
0.03

Todos Medical aims to develop and bring to market its revolutionary blood tests for cancer detection.

Our new cancer test will add a layer to currently available cancer screening and diagnostics.
Our goal is to help save lives through early detection while being minimally invasive to the patient.

  • Todos Medical’s vision is to become the standard of care in the way people are routinely checked for cancer (early detection).
  • The new method is easy to implement and at a low cost, currently targeting the mass population as the first choice for cancer detection.
  • The technology is a platform, and we are investigating methods for using our platform on other types of cancers (as a start we are focused on breast and colon cancers).

GERALD COMMISSIONG — CHIEF EXECUTIVE OFFICER

Mr. Commissiong is currently a director and President & CEO of Amarantus Bioscience Holdings, Inc. and is interim-CEO of Breakthrough Diagnostics, Inc., Todos’ joint venture with Amarantus. Mr. Commissiong has been responsible for Amarantus’ strategic transactions, licensing, research collaborations, mergers & acquisitions in therapeutics and diagnostics, as well as fund raising, having raised over of $50 million since inception. Prior to co-founding Amarantus, Mr. Commissiong played professional football for the Calgary Stampeders of the Canadian Football League. Mr. Commissiong received a B.Sc. in Management Science and Engineering with a focus on Financial Decisions from Stanford University.

RAMI ZIGDON, MBA — CHIEF BUSINESS OFFICER, CO-FOUNDER

Mr. Zigdon brings with him strong experience leading technology companies. Prior to founding Todos Medical with Dr. Udi Zelig and Mr. Shmuel Melman, he served as the country manager for Hitachi Semiconductors and Renesas Technology. He also served as a manager at Scitex Corporation (presently a division of Kodak), and as the Chief Technology Officer of NI Medical. Mr. Zigdon has been recognized for his leadership in the development and implementation of effective product development strategies and FDA submissions.

Mr. Zigdon has served as CEO since our inception in 2010 and was appointed as a director of our Company in May 2016. From May 2011 through June 2015, he also served as a director. From 2003 to 2009, Mr. Zigdon served as sales manager for Israel of Renesas Technology, a leading Japanese semiconductors corporation. Prior to this position, Mr. Zigdon served as the manager of Hitachi Semiconductors Israel and as embedded systems group manager at RDT. Mr. Zigdon has held various technical and management positions at Scitex (in Belgium), NI Medical and Spectronix.

Mr. Zigdon holds a BS in Biology from the Hebrew University in Jerusalem where he graduated with honors, a BS in Electrical Engineering from Ben Gurion University of the Negev, Beersheba, and a MBA from the Heriot-Watt University, Edinburgh.

Dr. JOSEPH WEE — MANAGING DIRECTOR, SINGAPORE

Dr. Joseph Wee was appointed managing director of our Singapore operations in July 2016. Dr. Wee has over 45 years of experience as productivity and business management consultant to SMEs, MNCs, Government Linked Companies and Government Agencies. Dr. Wee has held senior management and directorship positions in over 20 companies, including 3 publicly listed companies. Dr. Wee has also served as a member of Advisory Committees appointed by Government Agencies.

DANIEL HIRSCH, MPH — CHIEF FINANCIAL OFFICER

Mr. Hirsch as over 25 years of experience with a demonstrated history of working with public companies. Mr. Hirsch has management and business development expertise to go along with a strong background in investor relations.

PRIYANKA MISRA – VP OF CORPORATE DEVELOPMENT

Priyanka serves as the VP of Corporate Development at Todos Medical. Her main responsibilities include designing and implementing best practices for immediate sales progression, facilitating strategic partnerships, investor relations and marketing. Priyanka has a financial background with expertise in asset management. She previously served as a senior investment analyst at family office, Geller Advisors LLC, with a focus on both long-only traditional investments and private markets. Her responsibilities included sourcing new investment opportunities, providing investment manager due diligence, asset allocation research and portfolio construction. Prior to Geller, she worked at Goldman Sachs Asset Management in the Alternative Investments and Manager Selection group, where she focused on selecting best-in-class, long-only equity managers with an expertise in the international and global space, on behalf of institutional and private high net worth clients. Prior roles include serving as an domestic small-cap analyst at Bank of America Merrill Lynch and MTB Investment Advisors, respectively. Priyanka received a BA in Mathematical Economics from Brown University.

ANDREW A. BLUMENTHAL – VP OF BUSINESS DEVELOPMENT

Mr. Andrew Blumenthal, RN, ADS, and international lecturer, comes to Todos with over 20 years in the healthcare industry. Mr. Blumenthal is a seasoned health care professional with an extensive and eclectic background in project financing, technology development and implementation. Prior to joining Todos Medical, Mr. Blumenthal served in executive management positions, including head of health and medical projects at DDU Advisory Service, President of business development for Cross River Medical, partner at Goodlight Capital Group Latin America and managing director of Frontier Medical Ventures USA & Taiwan. Blumenthal is a C-suite officer in the California based Global Diabetes Network.

info@todosmedical.com